Volume 9, Issue 3 (2018)
JMBS 2018, 9(3): 369-384 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Tahoori H, Tabatabaeian H, Taghva M, Taghavi Fard S. An Analysis of the Innovation Ecosystem for Human Vaccines in Iran. JMBS 2018; 9 (3) :369-384
URL: http://biot.modares.ac.ir/article-22-21727-en.html
URL: http://biot.modares.ac.ir/article-22-21727-en.html
1- Industrial Management Department, Management & Accounting Faculty, Allameh Tabataba'i University, Tehran, Iran
2- Industrial Management Department, Management & Accounting Faculty, Allameh Tabataba'i University, Tehran, Iran, Industrial Management Department, Management & Accounting Faculty, Allameh Tabataba'i University, Tehran, Iran. Postal Code: - , hamidreza.tahoori2241@gmail.com
2- Industrial Management Department, Management & Accounting Faculty, Allameh Tabataba'i University, Tehran, Iran, Industrial Management Department, Management & Accounting Faculty, Allameh Tabataba'i University, Tehran, Iran. Postal Code: - , hamidreza.tahoori2241@gmail.com
Abstract: (6031 Views)
Aims: The innovation ecosystem states that innovation through interactive networks occurs at different levels. The network has a wide range of stakeholders that are complex in the innovation process as part of the innovation ecosystem. Considering the importance of the issue of prevention in the health sector and the importance of the role of biotechnology in this field, the aim of this study was to examine the innovation ecosystem of human vaccines in Iran.
Participants and Methods: In this qualitative, exploratory, and descriptive research, while investigating the dimensions of the ecosystem of innovation in literature and its main characteristics, the status of the innovation ecosystem of human vaccines was investigated in Iran. This study was carried out through content analysis of the current documents and deep and semi-structured interviews with experts in this field. Subsequently, a description of the current state of the vaccine innovation ecosystem was presented.
Findings: Most of the graduates did not have enough familiarity with the techniques needed to attend the industry. The existence of two major vaccine manufacturers, the Pasteur and Razi Institutes, were of important properties of ecosystems. The small number of service providers and existing service companies with knowledge-based organizations were of shortcomings. Shortcomings in the characteristics of stable and dynamic interaction in the innovation ecosystem of human vaccines in Iran were evident and the making policies to create or strengthen these characteristics was one of the important issues of Iran in this area.
Conclusion: Despite the abundance of elements and actors in this field, the innovation ecosystem of vaccines in Iran has not yet been formulated in a structured way, and its creation and development requires the characteristics of the innovation ecosystem and the resolution of its challenges.
Participants and Methods: In this qualitative, exploratory, and descriptive research, while investigating the dimensions of the ecosystem of innovation in literature and its main characteristics, the status of the innovation ecosystem of human vaccines was investigated in Iran. This study was carried out through content analysis of the current documents and deep and semi-structured interviews with experts in this field. Subsequently, a description of the current state of the vaccine innovation ecosystem was presented.
Findings: Most of the graduates did not have enough familiarity with the techniques needed to attend the industry. The existence of two major vaccine manufacturers, the Pasteur and Razi Institutes, were of important properties of ecosystems. The small number of service providers and existing service companies with knowledge-based organizations were of shortcomings. Shortcomings in the characteristics of stable and dynamic interaction in the innovation ecosystem of human vaccines in Iran were evident and the making policies to create or strengthen these characteristics was one of the important issues of Iran in this area.
Conclusion: Despite the abundance of elements and actors in this field, the innovation ecosystem of vaccines in Iran has not yet been formulated in a structured way, and its creation and development requires the characteristics of the innovation ecosystem and the resolution of its challenges.
Article Type: Original Research |
Subject:
Pharmaceutical Biotechnology
Received: 2018/04/21 | Accepted: 2018/05/31 | Published: 2018/09/22
Received: 2018/04/21 | Accepted: 2018/05/31 | Published: 2018/09/22
References
1. Biotechnology Development Council. Report on drawing the biotechnology roadmap in Iran [Internet]. Tehran: Biotechnology Development Council; 2016 [cited 2017 Feb 30]. Available from: http://biodc.isti.ir/uploads/14_1032_14_keshavarzi.pdf. [Persian] [Link]
2. Andrus Wagstaff. Big pharma has higher profit margins than any other industry [Internet]. Denver: Andrus Wagstaff; 2014 [cited 2017 Mar 25]. Available from: www.andruswagstaff.com/blog/2014. [Link]
3. Mohammadi M, Elyasi M, Taghavifard M, Hajihoseini H, Delavar A. Modeling the formation of technological innovation system in the Iranian biotechnology sector using structural equation modeling. Innov Manag J. 2012;1(1):21-40. [Persian] [Link]
4. Ghasem Sherbiani M, Radfar R, Abedi Z. Appropriate model for commercializing biotechnology in the environment in Iran. 4th Technology Management Conference. Tehran: Iranian Association for Management of Technology; 2010. [Persian] [Link]
5. Gobble MM. Charting the innovation ecosystem. Res Technol Manag. 2014;57(4):55-9. [Link]
6. Oksanen K, Hautamäki A. Transforming regions into innovation ecosystems: A model for renewing local industrial structures. Innov J. 2014;19(2):2-16. [Link]
7. Statista. Community pharmacy location in Great Britain 2014 [Internet]. Statista; 2014 [cited 2017 Apr 1]. Available from: https://www.statista.com/statistics/418681/community-pharmacy-location-in-great-britain/ [Link]
8. Allison SD, Martiny JBH. Resistance, resilience, and redundancy in microbial communities. Proc Natl Acad Sci. 2008;105(Suppl 1):11512-9. [Link] [DOI:10.1073/pnas.0801925105]
9. Oh D.S, Phillips F, Park S, Lee E. Innovation ecosystems: A critical examination. Technovation. 2016;54:1-6. [Link] [DOI:10.1016/j.technovation.2016.02.004]
10. Marandi V. Industrial Biotechnology Development in the Country, Importance and Solutions. 2nd National Biotechnology Conference. Tehran: National Institute of Genetic Engineering and Biotechnology; 2002. [Persian] [Link]
11. Ghodsi M. 50-year history of the Pasteur Institute of Iran. Tehran: Pasteur Institute of Iran; 1971. [Persian] [Link]
12. Marandi V. Case studies of goals realization and analysis of management approaches in a national development project. 2nd International Management Conference. Tehran: Industrial and Research Group of Aryana; 2004. [Persian] [Link]
13. Marandi V. Loghmani's Attitude: A Successful Strategy in Case Study of the Realization of Goals in a National Project. 5th Quality Management Conference. Tehran: Complex of International Summit Meeting; 2004. [Persian] [Link]
14. Schwartz-Barcott D, Suzie Kim H. An expansion and elaboration of the hybrid model of concept development. In Beth L. Rodgers, Kathleen Astin Knafl, editors. Concept Development in Nursing Foundations, Techniques, and Applications. Saunders; 2000. pp. 129-59. [Link]
15. Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual health res. 2005;15(9):1277-88. [Link] [DOI:10.1177/1049732305276687]
16. Bazargan A. An introduction to qualitative research methods and the combination of common approaches in behavioral sciences. 2nd Edition.Tehran: Didar; 2010. [Persian] [Link]
17. High Council of Cultural Revolution. Country Comprehensive Map [Internet]. Tehran: High Council of Cultural Revolution; 2011 [cited 2017 May 2]. Available from: http://aut.ac.ir/general/map.pdf. [Persian] [Link]
18. Research Center of the Islamic Consultative Assembly. The perspective of the Islamic Republic of Iran on the horizon of 1404 AH [Internet]. Tehran: Research Center of the Islamic Consultative Assembly; 2003 [cited 2017 May 10]. Available from: http://www.yu.ac.ir/uploads/Sanad%20Cheshmandaz_971.pdf. [Persian] [Link]
19. Tanabande F, editor. National Biotechnology Document of the Islamic Republic of Iran. Tehran: Ahaar; 2006. [Persian] [Link]
20. Biotechnology Development Council. Road Map and Development Plan for Biotechnology Scientists [Internet]. Tehran: Biotechnology Development Council; 2016 [cited 2017 Mar 5]. Available from: http://biodc.isti.ir [Persian] [Link]
21. Amid Development Management Consultants Company. Investigation and Analysis of the Role of Biotechnology Development Leadership in Biotechnology Innovation System of Iran [Internet]. Tehran: Amid Development Management Consultants Company; 2016 [cited 2017 Feb 19]. Available from: https://admc.ir/wpsite/wp-content/uploads/2017/07/full.pdf [Persian] [Link]
22. Biotechnology Development Council. Articles and Reports of the Vice Presidency of Science and Technology Presidency and Biotechnology Development Headquarters [Internet]. Tehran: Biotechnology Development Council; 2016 [cited 2017 Mar 5]. Available from: http://biodc.isti.ir [Persian] [Link]
23. Documents of the Working Group on Assessment and Qualification of Knowledge Companies. Vice Presidency for Science and Technology [Internet]. Tehran: Vice Presidency for Science and Technology 2017[cited 2017 Feb 19]. Available from: http://daneshbonyan.isti.ir/ [Persian] [Link]
24. Barati M, Kheradmandnia S, Zeynolabedini A, editors. Review of the entire 1396 budget bill for the whole country, Biotechnology sector [Internet]. Tehran: Islamic Parliament Research Center of the Islamic Republic of Iran; 2018 [cited 2017 May 23]. Available from: http://rc.majlis.ir/fa/report/show/1003984. [Persian] [Link]
25. Biotechnology Development Council. Performance report supporting the development of the production and trade of goods and biotechnology services within the framework of the goals of the Biotechnology Development Headquarters [Internet]. Tehran: Biotechnology Development Council; 2016 [cited 2017 May 23] Available from: http://biodc.isti.ir/. [Persian]. [Link]
26. United nations conference on trade and development. Science, technology and innovation policy review-Iran. United nations conference on trade and development; 2016. [Link]
27. McKinsey Global Institute. Iran: the $1 trillion growth opportunity? Biotechnology situation [Internet]. Manhattan: McKinsey Global Institute; 2016 [cited 2017 May 23]. Available from: https://www.markteintritt.ir/wp-content/uploads/Iran_Report.pdf [Link]
28. Biotechnology Development Council. Report on the Vaccine Working Group on Biotechnology Development [Internet]. Tehran: Biotechnology Development Council; 2017 [cited 2017 Apr 28]. Available from: http://biodc.isti.ir/. [Persian] [Link]
29. Biotechnology Development Council. Report on the Strategic Programs of the Vaccine Working Group [Internet]. Tehran: Biotechnology Development Council; 2017 [cited 2017 Apr 28]. Available from: http://biodc.isti.ir/. [Persian] [Link]
30. Biotechnology Development Council. Report of the 1996 Working Group on Vaccines [Internet]. Tehran: Biotechnology Development Council; 2016 [cited 2017 Apr 28]. Available from: http://biodc.isti.ir/. [Persian] [Link]
31. Biotechnology Development Council. Report of the 1996 Working Group on Vaccines [Internet]. Tehran: Biotechnology Development Council; 2017 [cited 2017 Apr 28]. Available from: http://biodc.isti.ir/. [Persian] [Link]
32. Biotechnology Development Council. Reports of the Vaccine Working Group in the area of the country's biotechnology map [Internet]. Tehran: Biotechnology Development Council; 2017 [cited 2017 Apr 28]. Available from: http://biodc.isti.ir/. [Persian] [Link]
33. Holloway I, Wheeler S. Qualitative research in nursing and healthcare. 3rd Edition. Hoboken: John Wiley & Sons; 2013. [Link]
34. Streubert HJ, Streubert Speziale HJ, Streubert Speziale H, Carpenter DR. Qualitative research in nursing: Advancing the humanistic imperative. 3rd Edition. Philadelphia: Lippincott Wiliams& Wilkins; 2003. [Link]
35. Biotechnology Development Council. Report of the Promotion and Human Capital Group of the Biotechnology Development Office [Internet]. Tehran: Biotechnology Development Council; 2017 [cited 2017 Apr 30] Available from: http://biodc.isti.ir/. [Persian] [Link]
36. Biotechnology Development Council. Report of the review and analysis of the role of the Biotechnology Development Directorate in the field of biotechnology innovation in Iran [Internet]. Tehran: Biotechnology Development Council; 2016 [cited 2017 Apr 30] Available from: http://biodc.isti.ir/. [Persian] [Link]
37. Golafshani, N. Understanding reliability and validity in qualitative research. Qualitative Rep. 2003;8(4):597-606. [Link]
38. Patton MQ. Two decades of developments in qualitative inquiry, a personal, experiential perspective. Qualitative Soc Work. 2002;1(3):261-83. [Link] [DOI:10.1177/1473325002001003636]
39. Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse EducToday. 2004;24(2):105-12 [Link] [DOI:10.1016/j.nedt.2003.10.001]
40. Anderson Jr EG, Parker GG. Integration of global knowledge networks. Prod Oper Manag. 2013;22(6):1446-63. [Link] [DOI:10.1111/poms.12181]
41. Sinkovec B. Building Knowledge Economy through Innovation Ecosystem: The Role of Innovation Hubs. Draft Analytical Compendium. 2014;1-46. [Link]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |